Cannabis Withdrawal Is Real, Driven by CB1 Receptor Changes, and May Be Worse for Women

Cannabis withdrawal involves downregulation of CB1 receptors that reverses with extended abstinence, and emerging evidence suggests women may experience faster onset and greater severity of certain withdrawal symptoms.

Schlienz, Nicolas J et al.·Current addiction reports·2017·Moderate EvidenceReview
RTHC-01513ReviewModerate Evidence2017RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

The review synthesized preclinical and clinical research on cannabis withdrawal, identifying several key findings.

Long-term cannabis use downregulates CB1 receptors throughout the brain. This reduced receptor density directly correlates with withdrawal severity during early abstinence. Importantly, CB1 receptor density recovers with extended abstinence, providing a neurobiological basis for why withdrawal symptoms are time-limited.

Sex differences are emerging as an important factor. Females showed increased rate and severity of a subset of cannabis withdrawal symptoms compared to males. This parallels sex differences seen in withdrawal from other substances and may have implications for treatment approaches.

The review also noted that most clinical withdrawal studies have predominantly male samples, creating a significant knowledge gap about the female experience of cannabis withdrawal.

Key Numbers

CB1 receptor density decreases with chronic cannabis use. Reduced CB1 density correlates with increased withdrawal severity. CB1 receptor density recovers with extended abstinence. Females show increased rate and severity of some withdrawal symptoms.

How They Did This

Narrative review of preclinical (animal) and clinical (human) research on the neurobiology of cannabis withdrawal, with specific attention to CB1 receptor dynamics, endocannabinoid system components, and sex differences.

Why This Research Matters

Cannabis withdrawal syndrome was only added to the DSM-5 in 2013, and awareness remains limited among both clinicians and the public. Understanding the neurobiological basis (CB1 downregulation) and the influence of sex on withdrawal severity can improve clinical support for people trying to quit cannabis.

The Bigger Picture

Cannabis withdrawal has been minimized for decades ("cannabis isn't addictive"), but the neurobiological evidence reviewed here shows a clear mechanism: chronic use downregulates the receptors, and when cannabis is removed, the depleted receptor population cannot maintain normal endocannabinoid signaling, producing withdrawal symptoms until receptors recover. The sex difference findings add another dimension to the growing recognition that addiction affects men and women differently.

What This Study Doesn't Tell Us

Many clinical studies are limited by small sample sizes and predominantly male participants. The review acknowledges that endocannabinoid enzymes, negative allosteric modulators, and other neurobiological systems that may influence withdrawal have been insufficiently studied. Preclinical findings may not directly translate to human withdrawal experiences.

Questions This Raises

  • ?How long does full CB1 receptor recovery take after different durations and intensities of cannabis use?
  • ?Why do women appear to experience more severe withdrawal for some symptoms?
  • ?Could pharmacological support during the CB1 recovery period reduce withdrawal severity?

Trust & Context

Key Stat:
CB1 receptor density recovers with extended abstinence, explaining why withdrawal is time-limited
Evidence Grade:
Moderate evidence from a narrative review synthesizing preclinical and clinical research on established neurobiological mechanisms.
Study Age:
Published in 2017. Cannabis withdrawal research has continued to expand.
Original Title:
Cannabis Withdrawal: A Review of Neurobiological Mechanisms and Sex Differences.
Published In:
Current addiction reports, 4(2), 75-81 (2017)
Database ID:
RTHC-01513

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

Is cannabis withdrawal real?

Yes. This review details the neurobiological mechanism: chronic cannabis use causes downregulation of CB1 receptors, and when cannabis is removed, the reduced receptor population cannot maintain normal function, causing withdrawal symptoms. The symptoms (irritability, anxiety, sleep disturbance, decreased appetite) are time-limited because CB1 receptors recover with abstinence.

Do women have worse cannabis withdrawal than men?

Emerging evidence suggests yes, at least for certain symptoms. Women showed increased rate and severity of a subset of withdrawal symptoms compared to men. However, most withdrawal studies have predominantly male samples, so the full picture of sex differences is not yet clear.

Read More on RethinkTHC

Cite This Study

RTHC-01513·https://rethinkthc.com/research/RTHC-01513

APA

Schlienz, Nicolas J; Budney, Alan J; Lee, Dustin C; Vandrey, Ryan. (2017). Cannabis Withdrawal: A Review of Neurobiological Mechanisms and Sex Differences.. Current addiction reports, 4(2), 75-81. https://doi.org/10.1007/s40429-017-0143-1

MLA

Schlienz, Nicolas J, et al. "Cannabis Withdrawal: A Review of Neurobiological Mechanisms and Sex Differences.." Current addiction reports, 2017. https://doi.org/10.1007/s40429-017-0143-1

RethinkTHC

RethinkTHC Research Database. "Cannabis Withdrawal: A Review of Neurobiological Mechanisms ..." RTHC-01513. Retrieved from https://rethinkthc.com/research/schlienz-2017-cannabis-withdrawal-a-review

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.